ARVN vs HSIC · rev $265.3M vs P/E 24, rev $6.83B
Arvinas Inc (ARVN) versus Henry Schein Inc (HSIC) — a side-by-side from cached financials, not a winner call.
Arvinas Inc (ARVN) is a biotechnology company listed on US.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Latest reported ARVN revenue for 2026-06-30 was $265.3M. Net income was $111.8M. ARVN currently screens at market cap $478.7M.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
ARVN currently screens at market cap $478.7M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Not investment advice. Open the ARVN and HSIC stock pages for the full models.
Not investment advice.